Citeline has launched TrialScope Intelligence, a new all-in-one knowledge base platform for clinical trial disclosures.
The new platform centralises the critical knowledge required in clinical research for timely compliance with trial requirements worldwide.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It complements the company’s TrialScope Disclose, which is claimed to be the most widely used platform for clinical trial disclosure management in the industry.
The company’s solutions and services portfolio covers all aspects of drug development, including clinical, regulatory and commercial. The comprehensive solution empowers sponsors of all sizes to manage clinical trial disclosures efficiently, while reducing the non-compliance risk.
It also provides granular, country specific clinical trial disclosure requirements, as well as collaborative, centralised communication across an organisation.
TrialScope Intelligence provides English translations, disclosure perspectives, analysis, and strategic insights along with professional support from the included Ask-the-Analyst service.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe new platform also improves partnership across teams and favours alignment with external parties, and reduces the time spent on gathering and interpreting disclosure requirements.
Citeline Clinical and Regulatory general manager David Laky said: “Our mission is to help sponsors understand their regulatory requirements in advance of starting a clinical trial, and reduce the risks of noncompliance by helping them sharpen their knowledge, strategise, plan out and manage timely clinical trial disclosures globally.
“With TrialScope Intelligence, sponsors know what, when, why and how they need to comply.”
